Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)

Name: Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
Published: 2013
License: Public Domain

Bayer · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

heart-failure

heart failure, worsening heart failure, heart failure with preserved ejection fraction, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)

Related documents